86 results on '"A Von Stackelberg"'
Search Results
2. 145 C1q dependent synaptic pruning in sepsis-associated encephalopathy (SAE)
3. Association of per- and polyfluoroalkyl substance exposure with fatty liver disease risk in US adults
4. EP01.02-001 Citizens’ Perspective on Combination Screening for Lung Cancer, COPD and CVD
5. Lung Screening Benefits and Challenges: A Review of The Data and Outline for Implementation
6. Association of per- and polyfluoroalkyl substance exposure with fatty liver disease risk in US adults
7. EP01.02-001 Citizens’ Perspective on Combination Screening for Lung Cancer, COPD and CVD
8. Targeted inhibitors and antibody immunotherapies: Novel therapies for paediatric leukaemia and lymphoma
9. COVID-19 pneumonia and its lookalikes: How radiologists perform in differentiating atypical pneumonias
10. Simultaneous presence of the “bullseye” and “reversed halo” sign at CT of COVID-19 pneumonia: A case report
11. Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials
12. Effects of intermittent and continuous calorie restriction on body weight and metabolism over 50 wk: a randomized controlled trial
13. Multicentre standardisation of chest MRI as radiation-free outcome measure of lung disease in young children with cystic fibrosis
14. Lung cancer prediction by Deep Learning to identify benign lung nodules
15. Lung Screening Benefits and Challenges: A Review of The Data and Outline for Implementation
16. COVID-19 pneumonia and its lookalikes: How radiologists perform in differentiating atypical pneumonias
17. Rational Response-Adapted Risk Stratification and Treatment for Children with Late Bone Marrow Relapses of B-Cell Precursor Acute Lymphoblastic Leukaemia: A Report from the ALL-REZ BFM Trial Group
18. Cleavage and Cell Adhesion Properties of Human Epithelial Cell Adhesion Molecule (HEPCAM)
19. Rational Response-Adapted Risk Stratification and Treatment for Children with Late Bone Marrow Relapses of B-Cell Precursor Acute Lymphoblastic Leukaemia: A Report from the ALL-REZ BFM Trial Group
20. Effects of intermittent and continuous calorie restriction on body weight and metabolism over 50 wk: a randomized controlled trial
21. MA20.10 Lung Cancer Prediction Using Deep Learning Software: Validation on Independent Multi-Centre Data
22. Multicentre standardisation of chest MRI as radiation-free outcome measure of lung disease in young children with cystic fibrosis
23. Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia – Long-term results of trial ALL-REZ BFM P95/96
24. Prognostic value of MRD-dynamics in childhood acute lymphoblastic leukemia treated according to the MB-2002/2008 protocols
25. MA20.10 Lung Cancer Prediction Using Deep Learning Software: Validation on Independent Multi-Centre Data
26. Results of a national survey of high-frequency fish consumers in the United States
27. A fail safe programmable logic controller
28. A Fast and Fail Safe Comparator of Binary Data with Ternary Result and Status Output
29. Variability of surface sediments in the Peru basin: dependence on water depth, productivity, bottom water flow, and seafloor topography
30. Toxicity, supportive care and costs of two chemotherapy protocols for treatment of childhood ALL in Russia
31. Hydrothermal activity associated with off-axis volcanism in the Peru Basin
32. The effects of intermittent calorie restriction on metabolic health: Rationale and study design of the HELENA Trial
33. Next-generation personalised medicine for high-risk paediatric cancer patients – The INFORM pilot study
34. A discussion on the use of probabilistic risk assessment in human health impact assessment
35. Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud
36. Cleavage and cell adhesion properties of human epithelial cell adhesion molecule (HEPCAM).
37. Cleavage and Cell Adhesion Properties of Human Epithelial Cell Adhesion Molecule (HEPCAM)
38. The formation of manganese nodules between the Clarion and Clipperton fracture zones southeast of Hawaii
39. HLA Identical Siblings Are the Best Donors for Children with ALL
40. Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud
41. 104 I-BFM SG trials on childhood ALL
42. HLA Identical Siblings Are the Best Donors for Children with ALL
43. Quantitative Monitoring of Minimal Residual Disease after Allogeneic Stem Cell Transplantation in Relapsed Childhood ALL Allows the Identification of Impending Relapse – Results of the ALL BFM SCT 2003 Trial
44. Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia – Long-term results of trial ALL-REZ BFM P95/96
45. Allogeneic HSCT from Unrelated and Sibling Donors are Equal for Children with Acute Lymphoblastic Leukemia
46. Prognostic value of MRD-dynamics in childhood acute lymphoblastic leukemia treated according to the MB-2002/2008 protocols
47. P20 Changes of tinnitus-related spontaneous brain activity before and after treatment-induced significant reduction of tinnitus symptoms
48. Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: A retrospective analysis of the ALL-REZ BFM Study Group
49. P20 Changes of tinnitus-related spontaneous brain activity before and after treatment-induced significant reduction of tinnitus symptoms
50. 104 I-BFM SG trials on childhood ALL
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.